The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and managed in the long term, explained Jennifer Vaughn, MD, of The Ohio State ...

Charleston AMC joined the ACCC MPN Quality Improvement Program to improve symptom tracking for MPN patients using the MPN-SAF TSS tool. The MPN-SAF TSS tool helps patients rate symptom severity, ...

Myeloproliferative neoplasms (MPNs) represent a cluster of conditions characterized by the excessive production of blood cells within the bone marrow. Among MPN patients, abnormal quantities of red ...

On behalf of the Canadian MPN Research Foundation, CURE spoke with Dr. Pierre Villeneuve, from the University of Ottawa, about MPN resources and support groups available to patients and loved ones.

People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according ...

Patients with myeloproliferative neoplasms (MPN) who later develop ph+ chronic myelogenous leukemia (CML): A case series. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This ...

An MPN advocate used his personal experiences to inform his dedication to patient-centered research and support programs for patients. An advocate’s personal connection to cancer has shaped his ...

Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers. The bone marrow of a mouse with a myeloproliferative neoplasm (left) shows fibrosis, or scar ...

First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in myeloproliferative neoplasms PRT12396 has completed GLP toxicology studies and is on track ...

Annual awards program recognizes extraordinary patients, health care professionals and caregivers for their outstanding efforts in bringing understanding, compassion, and strength to the ...